Trial intelligence / Profile preview

Enstilar Foam and Otezla in Psoriasis

NCT04555707Phase 4Unknown

Sponsor
DermResearch
Start
Jun 2020
Primary completion
Jun 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of calcipotriol in plaque psoriasis, sponsored by DermResearch. Primary endpoint: Physician Global Assessment Success at 4 weeks. Status: unknown.

02

Drugs

calcipotriol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT04555707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04555707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call